GINKGO BILOBA

It acts by inhibition of Platelet activating factor which is a likely factor in the development of cerebral thrombosis and multiple infarcts leading to cerebral impairment and dementia in the elderly. It also improves the microcirculation by normalising arterial & venous tone which is impaired in hypoxic areas, by its effects on catecholamine release and breakdown.Vascular disorders are one of the common factor in both cerebral impairment and peripheral vascular diseases. Ginkgo biloba extract through its effects on platelet aggregation and circulation improves peripheral circulation and total cerebral perfusion leading to its clinical efficacy in ameliorating symptoms of peripheral vascular disease and cerebral impairment.

Indications

Cerebral impairment due to organic degeneration of cortex, multiple vascular infarcts or a combination of both, characterized by memory loss, dizziness, tinnitus, impaired intellect & concentration, psycho-behavioural symptoms such as impaired alertness, mood disturbances, sociability disorders, headache, sleep disturbances & lack of initiative drive,& in sequelae of cerebrovascular accidents & brain trauma.Certain syndromes of vertigo,dizziness & tinnitus presumed to be due to involution of coc

Dosage

40 mg three times a day. Significant clinical improvement reportedly occurs in 4 weeks duration.

Contra-Indications

Acute phase of cerebrovascuar accidents, acute myocardial infarction, hypotension, pregnancy & hypersensitivity to ingredients.Ginkocer is not recommeded for treatment of paediatric memory deficits, behavioural disorders & mental retardation.

Special Precautions

Nausea, G.I. upsets, heartburn, dizziness, palpitation. Paediatrics: Not recommended. Pregnancy: Should not be used. Lactation: Safety not established. Elderly: Safe.

Side Effects

G.I. upset, nausea, heartburn mild & transient n nature.

Drug Interactions

None known.